|
End-of-day quote
Mexican S.E.
25/09/2026
|
5-day change | 1st Jan Change | ||
| 2,572.00 MXN | +5.24% |
|
+5.24% | +2.88% |
| 30/09 | Merck's experimental skin disease drug succeeds in mid-stage study | RE |
| 30/09 | Major drugmakers turn to China for licensing deals | RE |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -2.33% | -1.12% | -1.49% | -5.92% | +7.67% | +59.27% | +115.42% | +402.29% | +1,351.07% | 1,05600Cr | |
| -1.06% | -1.65% | -1.23% | +2.41% | +27.92% | +45.77% | +69.98% | +61.41% | +125.75% | 64TCr | |
| -0.65% | -1.36% | +2.39% | +2.86% | +14.49% | +17.22% | +75.49% | +140.34% | +316.41% | 47TCr | |
| -2.66% | -3.71% | -2.05% | +12.31% | +38.05% | +84.92% | +41.15% | +93.51% | +134.71% | 37TCr | |
| -0.06% | -4.12% | -2.68% | +3.04% | +6.37% | +36.31% | +39.39% | +3.27% | +44.38% | 34TCr | |
| -0.79% | +3.01% | -3.05% | -4.94% | +9.45% | +21.11% | +27.79% | +55.33% | +55.29% | 28TCr | |
| -1.19% | -3.09% | +2.59% | -14.11% | -10.95% | +10.75% | +10.61% | +39.02% | +144.33% | 25TCr | |
| -0.50% | +2.75% | -2.52% | +16.91% | +28.78% | +53.85% | +56.84% | +96.14% | +154.77% | 23TCr | |
| -1.47% | -2.37% | +2.31% | +17.98% | +21.44% | +32.35% | +98.89% | +110.11% | +91.43% | 19TCr | |
| +0.62% | -2.16% | -14.31% | -19.59% | -22.15% | -27.97% | -60.68% | -17.42% | +80.86% | 17TCr | |
| -0.70% | +2.11% | +2.00% | +17.03% | +14.54% | +19.58% | -14.02% | -34.48% | -14.41% | 16TCr | |
| -0.74% | +1.52% | -3.49% | +4.64% | +15.32% | +32.25% | +50.35% | +186.91% | +515.07% | 13TCr | |
| -0.73% | +0.24% | -6.28% | +6.56% | +15.68% | +41.34% | +7.51% | +2.94% | +15.83% | 13TCr | |
| -1.27% | -4.20% | -4.43% | +14.22% | +4.09% | +12.08% | +96.35% | +315.58% | +419.29% | 10TCr | |
| -1.29% | -3.88% | -1.16% | -7.45% | +0.41% | +20.69% | +22.79% | +4.31% | -11.04% | 9.82TCr | |
| +1.64% | -2.35% | -5.97% | -3.79% | -12.19% | -7.20% | -28.42% | -13.22% | +6.78% | 9.7TCr | |
| -5.35% | +5.48% | +39.55% | +176.28% | +553.00% | +660.24% | +86.44% | -49.18% | - | 8.12TCr | |
| +1.03% | -5.68% | -4.52% | +20.02% | -1.76% | +35.22% | -7.86% | +24.98% | +86.60% | 7.49TCr | |
| +0.51% | +3.72% | -1.53% | -5.67% | +12.64% | +28.70% | -12.68% | -25.45% | +44.03% | 6.77TCr | |
| Average | -0.10% | +0.19% | -0.31% | +12.25% | +38.04% | +61.92% | +35.54% | +73.49% | +197.84% | 25.95TCr | |
| Weighted average by Cap. | +0.07% | +0.28% | -1.01% | +4.30% | +21.71% | +48.55% | +57.26% | +137.31% | +403.68% |
- Stock Market
- Stocks
- NOVN Stock
- NVS N Stock
- Sector Novartis AG
Select your edition
All financial news and data tailored to specific country editions
